Tory, NY 6/6/09—Evident Technologies, a maker of quantum dots, has filed for Chapter 11 reorganization, seeking a $1.35 million debtor in financing package. “Defending a lawsuit in the Eastern District of Texas for patent infringement required us to spend at an unsustainable rate,” said Clinton Ballinger, CEO of Evident Technologies. “The restructuring plan associated with […]
San Diego, CA 7/1/09—Illumina has revised its forecast for the second quarter and year-end. The company now expects second-quarter revenues of approximately $161 million, compared to guidance of $168–$173 million (see IBO 5/15/09). Full-year revenues are now estimated to be $690–$720 million. Citing a sequential quarterly decline in array revenue for the change, Illumina highlighted […]
In calendar-year 2008 (CY08), total R&D spending in US dollars for 20 major analytical and life science instrument companies (see table, page 4) climbed 9.5% to $1.41 billion, compared to 10.9% growth in CY07. The median growth rate grew 60 basis points to 8.5% in CY08. The increase in R&D spending was primarily a result […]
June began with renewed economic optimism as data for May came in slightly better than expected. The markets were even reassured following the bankruptcy filing of GM on June 1. Although some market euphoria can be attributed to positive financial media spin, many observers believe the macroeconomic environment is improving and that the US will […]
Employment at instrument and lab product firms can be expected to decline this year. Numerous companies announced layoffs and hiring freezes in the fourth quarter of 2008 (see IBO 2/28/09) in response to a sharp and sudden downturn in sales, including Varian (see IBO 1/31/09) and Mettler-Toledo (see IBO 3/15/09). In 2009, so far, the […]
Productivity growth for 22 major publicly held laboratory instrument and product companies (see table, page 3) more than doubled in fiscal 2008. Productivity for the companies, as measured by average sales in US dollars per employee, increased 10.1%, up from a 5.4% growth in fiscal 2007, according to IBO’s analysis. Excluding the eight companies for […]
Over the past few months, the Department of Energy (DOE), National Institute of Standards and Technology (NIST) and National Science Foundation (NSF) have announced new details about their programs funded by the American Recovery and Reinvestment Act (ARRA) (see IBO 2/28/09). This article covers programs from these three agencies that are expected to benefit the […]
Company Announcements In March, Merck KgaA appointed Christina Shasserre, general manger of the Laboratory Business, as global head of Bioscience. She is based at EMD Chemicals’ Bioscience site in San Diego, California, where all of EMD’s core US Bioscience capabilities will be consolidated by year end. For the fiscal year ended March 31, Biotechnology-related Business […]
First-quarter 2009 Life Science Index sales declined 3.1% to $2,157 million, while operating profit slipped 0.8% to $356 million. However, operating margin gained 50 basis points to 16.6% of sales due to restructuring and cost saving initiatives. Of the 16 Index companies, Genetix and Tecan are the only two companies for which first-quarter estimates have […]
In what a number of publicly traded analytical instrument companies called their toughest quarter ever, the first quarter of calendar-year 2009 was a challenging environment for sales of analytical and laboratory instruments and even, in some cases, laboratory consumables. Revenues in reported currencies for 10 of the 11 companies profiled on pages 9–11 declined during […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
